Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Gross Profit: 2020-2022

  • SELLAS Life Sciences Group's Gross Profit fell 83.93% to $900,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $10.2 million, marking a year-over-year change of. This contributed to the annual value of $900,000 for FY2022, which is 87.84% down from last year.
  • SELLAS Life Sciences Group's Gross Profit amounted to $900,000 in Q1 2022, which was down 50.00% from $1.8 million recorded in Q2 2021.
  • In the past 5 years, SELLAS Life Sciences Group's Gross Profit ranged from a high of $5.6 million in Q1 2021 and a low of $900,000 during Q1 2022.
  • Moreover, its 3-year median value for Gross Profit was $1.9 million (2020), whereas its average is $2.5 million.
  • Data for SELLAS Life Sciences Group's Gross Profit shows a maximum YoY slumped of 83.93% (in 2022) over the last 5 years.
  • Over the past 3 years, SELLAS Life Sciences Group's Gross Profit (Quarterly) stood at $1.9 million in 2020, then reached $1.8 million in 2021, then plummeted by 83.93% to $900,000 in 2022.
  • Its Gross Profit stands at $900,000 for Q1 2022, versus $1.8 million for Q2 2021 and $5.6 million for Q1 2021.